Trials / Completed
CompletedNCT01048372
Observational Study of Blood Treated With Cytolin
An Observational Study to Determine the In-vitro Immunologic and Virology Activity of Cytolin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- CytoDyn, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Primary Objective: To determine the mechanism of Cytolin's effect on HIV replication from blood drawn from HIV-positive and HIV-negative individuals after exposure to Cytolin.
Detailed description
The initial phase of this in vitro study regarding the potential mechanisms of action of Cytolin was completed in January 2011. Given the data set to date, a decision has been made to extend the study. The extension will allow the Company to further confirm and extend the initial findings regarding the potential mechanism of action of Cytolin.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-01-01
- Completion
- 2012-12-01
- First posted
- 2010-01-13
- Last updated
- 2013-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01048372. Inclusion in this directory is not an endorsement.